Skip to main content
MedPathMedPath Home
Clinical Trials/NCT05450874
NCT05450874
Completed
Not Applicable

A Novel MSE Score to Predict the Postoperative Prognosis of Patients With Ruptured Hepatocellular Carcinoma

Tongji Hospital0 sites300 target enrollmentFebruary 1, 2010
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHCC

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
HCC
Sponsor
Tongji Hospital
Enrollment
300
Primary Endpoint
overall survival
Status
Completed
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

Develop and validate a novel scoring system based on pathological factors to predict the postoperative survival of patients with rHCC.Patients with rHCC who underwent hepatectomy were recruited from two hospitals.Exploring whether this scoring system is related to prognosis

Registry
clinicaltrials.gov
Start Date
February 1, 2010
End Date
June 1, 2022
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •a diagnosis of ruptured tumor confirmed by enhanced computed tomography (CT) and/or abdominal magnetic resonance imaging (MRI),
  • •a diagnosis of HCC made by two experienced pathologists

Exclusion Criteria

  • •extrahepatic HCC metastasis
  • •death within 1 month after surgery

Outcomes

Primary Outcomes

overall survival

Time Frame: 2010-2022

Time from the first postoperative day to survival at the last follow-up

Similar Trials

Recruiting
Not Applicable
Developement of the score predicting postoperative hemorrhage in the patients undergoing antithrombotic therapyantithrombotic therapy
JPRN-UMIN000045045Department of Dentistry, National cardiovascular Center1,500
Completed
Not Applicable
Proposal of a Score to Detect the Need for Postoperative Intensive Care Unit Admission After Bariatric SurgeryBariatric Surgery Procedures
NCT02976649Ain Shams University111
Recruiting
Not Applicable
Biomarkers for predicting postoperative complications following anatomic lung resectioIn this prospective study we assess the predictive ability of B-type natriuretic peptide (BNP) and lactate for complications after anatomic lung rescection.C34Malignant neoplasm of bronchus and lung
DRKS00014027Abteilung für Thoraxchirurgie,Klinik Schillerhöhe,Robert-Bosch-KrankenhausProf. Dr. med. Godehard Friedel, Dr. med. Ruoyu Zhang400
Completed
Not Applicable
A Novel Nomogram to Predict the Postoperative Overall Survival in Gastrointestinal Cancer PatientsGastrointestinal Cancers - StomachGastrointestinal Cancers - ColorectalPrognosisSurvival AnalysisNutrition Assessment
NCT05620537Wang Xinying808
Completed
Not Applicable
Efficacy Safety Score in Postoperative ManagementPain, PostoperativePostoperative Nausea and Vomiting
NCT03438578St. Olavs Hospital200